The Scientific World Journal

The Scientific World Journal / 2011 / Article

Review Article | Open Access

Volume 11 |Article ID 585342 | https://doi.org/10.1100/tsw.2011.42

Irena Dimov, Deasanka Tasic-Dimov, Irena Conic, Vladisav Stefanovic, "Glioblastoma Multiforme Stem Cells", The Scientific World Journal, vol. 11, Article ID 585342, 29 pages, 2011. https://doi.org/10.1100/tsw.2011.42

Glioblastoma Multiforme Stem Cells

Academic Editor: Dave Carter
Received15 Nov 2010
Revised11 Jan 2011
Accepted17 Jan 2011

Abstract

Glioblastoma multiforme (GBM) is an aggressive, malignant, and lethal brain tumor, resistant to all current forms of treatment. The rapidly emerging focus on cancer stem cells embodies a paradigm shift in our understanding of tumor pathogenesis, while the development of powerful genome-wide screening techniques has provided cause for optimism related to the development of more reliable therapies primarily targeting GBM stem cells (GBMSCs). There are promising mounting data on providing new molecular targets and predictive markers of response, leading to more effective therapies of GBM, guided by patient-specific genetic and epigenetic profiling. However, the achievement of efficient GBMSC targeting also requires an adequate understanding of the unique microenvironment, and the relationship with the immune system in the central nervous system (CNS) and CNS tumors. The endogenous immune regulation is likely to limit or abrogate the efficacy of the host's immune response, as well as the developed immunotherapeutic strategies at present. Therefore, a comprehensive understanding of the mechanisms underlying the GBM-induced immunosuppression is indispensable. This review presents a summary of the present knowledge both on GBMSCs and the GBM, and/or GBMSC-related mechanisms of developing both local and systemic immunosuppression, of which an understanding may lead to the development of the novel and effective therapeutic strategies.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views511
Downloads1460
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.